Literature DB >> 30721966

Kynurenine Is a Cerebrospinal Fluid Biomarker for Bacterial and Viral Central Nervous System Infections.

Kurt-Wolfram Sühs1,2, Natalia Novoselova3,4, Maike Kuhn5,3, Lena Seegers1, Volkhard Kaever5, Kirsten Müller-Vahl6, Corinna Trebst1, Thomas Skripuletz1, Martin Stangel1,2, Frank Pessler2,3,7.   

Abstract

BACKGROUND: The tryptophan-kynurenine-nicotinamide adenine dinucleotide (oxidized; NAD+) pathway is closely associated with regulation of immune cells toward less inflammatory phenotypes and may exert neuroprotective effects. Investigating its regulation in central nervous system (CNS) infections would improve our understanding of pathophysiology and end-organ damage, and, furthermore, open doors to its evaluation as a source of diagnostic and/or prognostic biomarkers.
METHODS: We measured concentrations of kynurenine (Kyn) and tryptophan (Trp) in 221 cerebrospinal fluid samples from patients with bacterial and viral (due to herpes simplex, varicella zoster, and enteroviruses) meningitis/encephalitis, neuroborreliosis, autoimmune neuroinflammation (due to anti-N-methyl-D-aspartate receptor [NMDA] encephalitis and multiple sclerosis), and noninflamed controls (ie, individuals with Bell palsy, normal pressure hydrocephalus, or Tourette syndrome).
RESULTS: Kyn concentrations correlated strongly with CSF markers of neuroinflammation (ie, leukocyte count, lactate concentration, and blood-CSF-barrier dysfunction), were highly increased in bacterial and viral CNS infections, but were low or undetectable in NMDA encephalitis, multiple sclerosis, and controls. Trp concentrations were decreased mostly in viral CNS infections and neuroborreliosis. Multiple logistic regression analysis revealed that combinations of Kyn concentration, Trp concentration, and Kyn/Trp concentration ratio with leukocyte count or lactate concentration were accurate classifiers for the clinically important differentiation between neuroborreliosis, viral CNS infections, and autoimmune neuroinflammation.
CONCLUSIONS: The Trp-Kyn-NAD+ pathway is activated in CNS infections and provides highly accurate CSF biomarkers, particularly when combined with standard CSF indices of neuroinflammation.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Borreliazzm321990 ; Biomarkers; central nervous system; diagnosis; infection; kynurenine; metabolites; tryptophan

Mesh:

Substances:

Year:  2019        PMID: 30721966     DOI: 10.1093/infdis/jiz048

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Organ-specific small non-coding RNA responses in domestic (Sudani) ducks experimentally infected with highly pathogenic avian influenza virus (H5N1).

Authors:  Mohamed Samir; Ramon O Vidal; Fatma Abdallah; Vincenzo Capece; Frauke Seehusen; Robert Geffers; Ashraf Hussein; Ahmed A H Ali; Stefan Bonn; Frank Pessler
Journal:  RNA Biol       Date:  2019-10-04       Impact factor: 4.652

Review 2.  Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan.

Authors:  Raul Castro-Portuguez; George L Sutphin
Journal:  Exp Gerontol       Date:  2020-01-16       Impact factor: 4.032

Review 3.  Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis.

Authors:  Vanessa X Tan; Gilles J Guillemin
Journal:  Front Neurosci       Date:  2019-09-20       Impact factor: 4.677

4.  Phosphatidylcholine PC ae C44:6 in cerebrospinal fluid is a sensitive biomarker for bacterial meningitis.

Authors:  Leonardo Silva de Araujo; Kevin Pessler; Kurt-Wolfram Sühs; Natalia Novoselova; Frank Klawonn; Maike Kuhn; Volkhard Kaever; Kirsten Müller-Vahl; Corinna Trebst; Thomas Skripuletz; Martin Stangel; Frank Pessler
Journal:  J Transl Med       Date:  2020-01-07       Impact factor: 5.531

Review 5.  Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives.

Authors:  Tamás Biernacki; Dániel Sandi; Krisztina Bencsik; László Vécsei
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

6.  Targeted metabolomic profiling of cerebrospinal fluid from patients with progressive multifocal leukoencephalopathy.

Authors:  Yi Luo; Nora Möhn; Amani Al-Mekhlafi; Sven Schuchardt; Thomas Skripuletz; Wolfram Sühs; Frank Pessler; Martin Stangel
Journal:  PLoS One       Date:  2020-11-24       Impact factor: 3.240

7.  The Kynurenine Pathway is Differentially Activated in Children with Lyme Disease and Tick-Borne Encephalitis.

Authors:  Ronny Wickström; Åsa Fowler; Michel Goiny; Vincent Millischer; Sofia Ygberg; Lilly Schwieler
Journal:  Microorganisms       Date:  2021-02-04

8.  The Anaesthetic Biobank of Cerebrospinal fluid: a unique repository for neuroscientific biomarker research.

Authors:  Celien Tigchelaar; Sawal D Atmosoerodjo; Martijn van Faassen; Klaas J Wardenaar; Peter P De Deyn; Robert A Schoevers; Ido P Kema; Anthony R Absalom
Journal:  Ann Transl Med       Date:  2021-03

9.  Elevated Free Phosphatidylcholine Levels in Cerebrospinal Fluid Distinguish Bacterial from Viral CNS Infections.

Authors:  Amani Al-Mekhlafi; Kurt-Wolfram Sühs; Sven Schuchardt; Maike Kuhn; Kirsten Müller-Vahl; Corinna Trebst; Thomas Skripuletz; Frank Klawonn; Martin Stangel; Frank Pessler
Journal:  Cells       Date:  2021-05-06       Impact factor: 6.600

Review 10.  Host Diagnostic Biomarkers of Infection in the ICU: Where Are We and Where Are We Going?

Authors:  Aaron J Heffernan; Kerina J Denny
Journal:  Curr Infect Dis Rep       Date:  2021-02-12       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.